uric acid has been researched along with Status Epilepticus in 3 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Status Epilepticus: A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30)
| Excerpt | Relevance | Reference |
|---|---|---|
| "RSE was defined as seizure continuing after the first- and second-line treatments." | 5.51 | Uric acid is a useful marker to differentiate between responsive and refractory status epilepticus. ( Choi, JY; Hong, JM; Huh, K; Kim, BG; Kim, TJ, 2019) |
| "RSE was defined as seizure continuing after the first- and second-line treatments." | 1.51 | Uric acid is a useful marker to differentiate between responsive and refractory status epilepticus. ( Choi, JY; Hong, JM; Huh, K; Kim, BG; Kim, TJ, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Ma, L | 1 |
| Ma, X | 2 |
| Li, J | 1 |
| Li, D | 1 |
| Lin, X | 1 |
| Su, Z | 1 |
| Chen, X | 1 |
| Choi, JY | 1 |
| Hong, JM | 1 |
| Kim, TJ | 1 |
| Kim, BG | 1 |
| Huh, K | 1 |
| Makki, N | 1 |
| Hajj, G | 1 |
| Schmidt, GA | 1 |
1 review available for uric acid and Status Epilepticus
| Article | Year |
|---|---|
Seizure-induced acute urate nephropathy: case report and review.
Topics: Acute Kidney Injury; Adult; Anticonvulsants; Humans; Kidney Function Tests; Male; Renal Replacement | 2013 |
2 other studies available for uric acid and Status Epilepticus
| Article | Year |
|---|---|
Simple and effective serum biomarkers potential for predicting status epilepticus in anti-N-methyl-D-aspartate receptor encephalitis.
Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Biomarkers; Humans; Retrospective Studies; Status E | 2022 |
Uric acid is a useful marker to differentiate between responsive and refractory status epilepticus.
Topics: Adult; Aged; Anticonvulsants; Biomarkers; Female; Hospitalization; Humans; Intensive Care Units; Mal | 2019 |